Drug intelligence / Profile preview

Anachil Cream

Development stage: Unknown
Lead developer: Gonan Pharma
Modality: Small Molecules
Administration: Topical

Overview

Anachil Cream is a topical pharmaceutical product marketed by Gonan Pharma, an Indian pharmaceutical company based in Mumbai. It is a finished commercial formulation categorized as a topical cream. While specific active ingredients are not detailed in the company's general catalog, the product is positioned within therapeutic categories such as orthopedics and general medicine, suggesting its use as a topical analgesic or anti-inflammatory agent for localized pain relief. As a commercial generic product, it is available in the Indian market for retail sale and is not currently an investigational candidate in clinical development.

Brand names: Anachil Cream

Targets

ADRA1A (α1A)NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Anachil Cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anachil Cream.

Explore the full profile